| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |